Apex Biotechnology Corp. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$145,664,000 NT$177,828,000
Jan-May Revenue NT$816,424,000 NT$923,843,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.
Table: Apex Biotechnology May Rev NT$145.7M Vs NT$177.8M
Earlier from Apex Biotechnology
- Table: Apex Biotechnology Apr Rev NT$151.0M Vs NT$187.3M
- Table: Apex Biotechnology Mar Rev NT$141.4M Vs NT$186.4M